Login
Home
Charts
Search
Watchlist
Products

Health X Platform Ltd

HEALTHX·NSE
298.15+0.39%Tue, 22 Sept '26 12:21

Health X Platform Ltd

HEALTHX
NSE
298.15
+0.39%
|Tue, 22 Sept '26 12:21
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
948Cr
Close
Close Price
298.15
Industry
Industry
Pharmacy Distribution
PE
Price To Earnings
PS
Price To Sales
0.65
Revenue
Revenue
1,468Cr
Rev Gr TTM
Revenue Growth TTM
28.85%
PAT Gr TTM
PAT Growth TTM
82.23%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
358375307270274281286298301346374447
Growth YoY
Revenue Growth YoY%
41.033.5-2.1-19.6-23.7-24.9-6.810.410.222.930.849.7
Expenses
ExpensesCr
355371317273278305311292324356399455
Operating Profit
Operating ProfitCr
33-11-2-5-24-256-23-10-25-8
OPM
OPM%
0.90.9-3.5-0.9-1.7-8.4-8.82.0-7.5-3.0-6.7-1.9
Other Income
Other IncomeCr
1020182822-1222256141413
Interest Expense
Interest ExpenseCr
000000000001
Depreciation
DepreciationCr
223211111222
PBT
PBTCr
1121525-174-39-530-191-152
Tax
TaxCr
-21-29-25-231-224-31-20
PAT
PATCr
13203450-151-401827-150-132
Growth YoY
PAT Growth YoY%
-28.0882.6257.7103.8-1,251.6-298.3-48.7-46.889.8100.9-173.8-92.5
NPM
NPM%
3.65.411.218.5-55.1-14.26.28.9-5.10.1-3.50.5
EPS
EPS
-2.5-0.25.29.8-34.4-8.54.37.5-4.00.3-3.50.8
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
358375307270274281286298301346374447
Growth YoY
Revenue Growth YoY%
41.033.5-2.1-19.6-23.7-24.9-6.810.410.222.930.849.7
Expenses
ExpensesCr
355371317273278305311292324356399455
Operating Profit
Operating ProfitCr
33-11-2-5-24-256-23-10-25-8
OPM
OPM%
0.90.9-3.5-0.9-1.7-8.4-8.82.0-7.5-3.0-6.7-1.9
Other Income
Other IncomeCr
1020182822-1222256141413
Interest Expense
Interest ExpenseCr
000000000001
Depreciation
DepreciationCr
223211111222
PBT
PBTCr
1121525-174-39-530-191-152
Tax
TaxCr
-21-29-25-231-224-31-20
PAT
PATCr
13203450-151-401827-150-132
Growth YoY
PAT Growth YoY%
-28.0882.6257.7103.8-1,251.6-298.3-48.7-46.889.8100.9-173.8-92.5
NPM
NPM%
3.65.411.218.5-55.1-14.26.28.9-5.10.1-3.50.5
EPS
EPS
-2.5-0.25.29.8-34.4-8.54.37.5-4.00.3-3.50.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
861331592203855486311,0401,3761,1111,3191,468
Growth
Revenue Growth%
78.454.119.937.975.442.215.264.732.3-19.218.828.9
Expenses
ExpensesCr
1171551752564415626801,0841,3701,1671,3711,534
Operating Profit
Operating ProfitCr
-31-22-15-36-55-14-49-445-56-52-67
OPM
OPM%
-36.0-16.7-9.7-16.5-14.4-2.6-7.7-4.20.4-5.0-4.0-4.5
Other Income
Other IncomeCr
243233122460605846
Interest Expense
Interest ExpenseCr
131211211011
Depreciation
DepreciationCr
776654489677
PBT
PBTCr
-37-28-12-42-58-161,109-122-31-204-2-31
Tax
TaxCr
0121-51244-23-36-70-1-5
PAT
PATCr
-37-29-15-43-52-17865-996-134-1-26
Growth
PAT Growth%
-146.621.848.5-191.0-21.667.25,161.5-111.5105.9-2,381.898.982.2
NPM
NPM%
-42.4-21.5-9.2-19.5-13.5-3.1137.0-9.60.4-12.0-0.1-1.8
EPS
EPS
-11.5-9.0-3.7-11.8-12.2-3.3222.7-22.72.8-28.70.4-6.3
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
861331592203855486311,0401,3761,1111,3191,468
Growth
Revenue Growth%
78.454.119.937.975.442.215.264.732.3-19.218.828.9
Expenses
ExpensesCr
1171551752564415626801,0841,3701,1671,3711,534
Operating Profit
Operating ProfitCr
-31-22-15-36-55-14-49-445-56-52-67
OPM
OPM%
-36.0-16.7-9.7-16.5-14.4-2.6-7.7-4.20.4-5.0-4.0-4.5
Other Income
Other IncomeCr
243233122460605846
Interest Expense
Interest ExpenseCr
131211211011
Depreciation
DepreciationCr
776654489677
PBT
PBTCr
-37-28-12-42-58-161,109-122-31-204-2-31
Tax
TaxCr
0121-51244-23-36-70-1-5
PAT
PATCr
-37-29-15-43-52-17865-996-134-1-26
Growth
PAT Growth%
-146.621.848.5-191.0-21.667.25,161.5-111.5105.9-2,381.898.982.2
NPM
NPM%
-42.4-21.5-9.2-19.5-13.5-3.1137.0-9.60.4-12.0-0.1-1.8
EPS
EPS
-11.5-9.0-3.7-11.8-12.2-3.3222.7-22.72.8-28.70.4-6.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
3232323232323232323232
Reserves
ReservesCr
186158144106173163790717726638609
Current Liabilities
Current LiabilitiesCr
3149272266606811079105
Non Current Liabilities
Non Current LiabilitiesCr
775833116102725
Total Liabilities
Total LiabilitiesCr
2562512362313162931,2781,2061,150974936
Current Assets
Current AssetsCr
891089566137130508575354267
Non Current Assets
Non Current AssetsCr
167143141165178162770631795708
Total Assets
Total AssetsCr
2562512362313162931,2781,2061,150974936
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
3232323232323232323232
Reserves
ReservesCr
186158144106173163790717726638609
Current Liabilities
Current LiabilitiesCr
3149272266606811079105
Non Current Liabilities
Non Current LiabilitiesCr
775833116102725
Total Liabilities
Total LiabilitiesCr
2562512362313162931,2781,2061,150974936
Current Assets
Current AssetsCr
891089566137130508575354267
Non Current Assets
Non Current AssetsCr
167143141165178162770631795708
Total Assets
Total AssetsCr
2562512362313162931,2781,2061,150974936

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-12-2-49-30-69-31-207-11236-17-74
Investing Cash Flow
Investing Cash FlowCr
-1421-2-2221220133-34-1171
Financing Cash Flow
Financing Cash FlowCr
13533261034-11-2-20-80
Net Cash Flow
Net Cash FlowCr
075-611-51190-1918
Free Cash Flow
Free Cash FlowCr
-180-55-33-71-31-212-12822-27
CFO To PAT
CFO To PAT%
32.76.6331.469.9132.8178.5-23.9112.6612.813.05,091.7
CFO To EBITDA
CFO To EBITDA%
38.58.5316.382.7125.0213.7425.8254.7662.330.9141.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-12-2-49-30-69-31-207-11236-17-74
Investing Cash Flow
Investing Cash FlowCr
-1421-2-2221220133-34-1171
Financing Cash Flow
Financing Cash FlowCr
13533261034-11-2-20-80
Net Cash Flow
Net Cash FlowCr
075-611-51190-1918
Free Cash Flow
Free Cash FlowCr
-180-55-33-71-31-212-12822-27
CFO To PAT
CFO To PAT%
32.76.6331.469.9132.8178.5-23.9112.6612.813.05,091.7
CFO To EBITDA
CFO To EBITDA%
38.58.5316.382.7125.0213.7425.8254.7662.330.9141.7

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2053153533801993711,134700965772831948
Price To Earnings
Price To Earnings
1.8108.7704.3
Price To Sales
Price To Sales
2.32.32.21.70.50.70.60.70.70.70.60.7
Price To Book
Price To Book
0.91.72.02.81.01.91.40.91.31.11.31.5
EV To EBITDA
EV To EBITDA
-6.8-13.6-22.8-10.3-3.4-25.8-18.9-11.5169.5-13.6-15.8-14.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
98.998.998.999.099.499.699.599.799.999.8
OPM
OPM%
-36.0-16.7-9.7-16.5-14.4-2.6-7.7-4.20.4-5.0-4.0-4.5
NPM
NPM%
-42.4-21.5-9.2-19.5-13.5-3.1137.0-9.60.4-12.0-0.1-1.8
ROCE
ROCE%
-15.2-12.0-6.3-28.9-27.1-7.5135.3-16.2-3.9-30.4-0.2-0.2
ROE
ROE%
-16.8-15.1-8.4-31.2-25.4-8.8105.3-13.30.8-19.9-0.2-0.2
ROA
ROA%
-14.3-11.4-6.3-18.6-16.5-5.867.7-8.30.5-13.7-0.1-0.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2053153533801993711,134700965772831948
Price To Earnings
Price To Earnings
1.8108.7704.3
Price To Sales
Price To Sales
2.32.32.21.70.50.70.60.70.70.70.60.7
Price To Book
Price To Book
0.91.72.02.81.01.91.40.91.31.11.31.5
EV To EBITDA
EV To EBITDA
-6.8-13.6-22.8-10.3-3.4-25.8-18.9-11.5169.5-13.6-15.8-14.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
98.998.998.999.099.499.699.599.799.999.8
OPM
OPM%
-36.0-16.7-9.7-16.5-14.4-2.6-7.7-4.20.4-5.0-4.0-4.5
NPM
NPM%
-42.4-21.5-9.2-19.5-13.5-3.1137.0-9.60.4-12.0-0.1-1.8
ROCE
ROCE%
-15.2-12.0-6.3-28.9-27.1-7.5135.3-16.2-3.9-30.4-0.2-0.2
ROE
ROE%
-16.8-15.1-8.4-31.2-25.4-8.8105.3-13.30.8-19.9-0.2-0.2
ROA
ROA%
-14.3-11.4-6.3-18.6-16.5-5.867.7-8.30.5-13.7-0.1-0.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Health X Platform Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/b2yefhtgmz5i92vjgxb7jmnw.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/kyxfai1zhf9rb24o3uvnb781.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/0f8vv55wwx4wl75uv016ol39.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/45hr0lfa4jnb8lt3ack9q53x.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/gq8s51xd4ijjy6r3sfj3eit4.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/2zrnfvh5ku7rjkl266kanyu0.pdf
  • Q3 FY2024 Earnings Call Transcript (Dec 2023, PDF): https://www.stockscans.in/document/6xwoefowho7y9mi0vb1aqdvl.pdf
  • Q2 FY2024 Earnings Call Transcript (Sep 2023, PDF): https://www.stockscans.in/document/jrdi4xuu8yux7vxng0ycig6l.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/j5mir6ixl614io23ioq68xxb.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/wc39m6z0zml6z6s4cujy7oun.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/6cro0cntbk3edo7ba23u3zux.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/uytvfb8mlqe87dgyymt9ru3p.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/zd0aglm7nq40v1thcw2z9y3r.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/pac9xm4p50sj8t6bczmsy6ct.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/6yj9mvmaboflbto7qif1ut8o.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/7bxpclj22q9az2mejs57sviy.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/w6ajrx312rvit6x40anlbjp9.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/kswy8n4up5jqiilbnt2fi2i0.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/wrdym90uor0r6jkmz0y4voth.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/o696p0z66zq9x816tegradcj.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/wq6sxoez0woxgpycbktxuxel.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/7ju6yffey7vwskv6gzkj1lvk.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/je8mqky3xuov5bhx4azi43mk.pdf
  • Q4 FY2024 Investor Presentation (Mar 2024, PDF): https://www.stockscans.in/document/0oxokcpwb0nn9gpwt4cbvkgl.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/7xl8nozhyw0pvd3qks9r53wl.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/litox7qdsovp2ffe7in1l5nf.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/pbgn1phpgj0xm1s822yb4u3n.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/f0syijub0s3wf3tbnkbnsxck.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/w2fssgz1h4x16h81lobcqs4n.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/rssog1ji4fkiyd1l8zbcnmrf.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/wfha77rle0v0ujog5ict26hz.pdf

Concall Transcript Summaries — Health X Platform Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AHEALTHX/transcript-notes/202606/b2yefhtgmz5i92vjgxb7jmnw.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AHEALTHX/transcript-notes/202603/kyxfai1zhf9rb24o3uvnb781.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AHEALTHX/transcript-notes/202512/0f8vv55wwx4wl75uv016ol39.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AHEALTHX/transcript-notes/202509/45hr0lfa4jnb8lt3ack9q53x.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AHEALTHX/transcript-notes/202503/gq8s51xd4ijjy6r3sfj3eit4.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AHEALTHX/transcript-notes/202409/2zrnfvh5ku7rjkl266kanyu0.pdf
  • Q3 FY2024 Concall Transcript Summary (Dec 2023): https://www.stockscans.in/company/NSE%3AHEALTHX/transcript-notes/202312/6xwoefowho7y9mi0vb1aqdvl.pdf
  • Q2 FY2024 Concall Transcript Summary (Sep 2023): https://www.stockscans.in/company/NSE%3AHEALTHX/transcript-notes/202309/jrdi4xuu8yux7vxng0ycig6l.pdf